Literature DB >> 6336692

Pulmonary alveolar proteinosis. Staining for surfactant apoprotein in alveolar proteinosis and in conditions simulating it.

G Singh, S L Katyal, C W Bedrossian, R M Rogers.   

Abstract

Formalin fixed paraffin-embedded lung tissues (n = 13) or lavage material (n = 4) from 17 patients in whom alveolar proteinosis was the primary disease and ten patients with other primary diagnoses but lung morphology similar to alveolar proteinosis were examined. The tissues were stained by the periodic acid-Schiff method and by the immunoperoxidase method for surfactant specific apoprotein. The intra-alveolar material in patients with primary alveolar proteinosis stained uniformly for surfactant specific apoprotein, whereas the staining was focal in patients with other primary diseases associated with intra-alveolar accumulation of proteinacious material. In both situations, the number of inflammatory cells, especially macrophages, was small. These observations extend an earlier impression about the presence of surfactant specific apoprotein in alveolar spaces in patients with primary alveolar proteinosis and provide a distinction between primary alveolar proteinosis and morphologically similar appearance due to other causes, ie, secondary alveolar proteinosis. The lack of macrophages in the affected tissue appears to be the major pathogenetic factor in alveolar proteinosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6336692     DOI: 10.1378/chest.83.1.82

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

Review 1.  Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis.

Authors:  P L Shah; D Hansell; P R Lawson; K B Reid; C Morgan
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

Review 2.  Lung surfactant and pulmonary toxicology.

Authors:  H P Haagsman; L M van Golde
Journal:  Lung       Date:  1985       Impact factor: 2.584

Review 3.  The Role of Surfactant in Lung Disease and Host Defense against Pulmonary Infections.

Authors:  SeungHye Han; Rama K Mallampalli
Journal:  Ann Am Thorac Soc       Date:  2015-05

Review 4.  Secondary alveolar proteinosis in cancer patients.

Authors:  S Ladeb; J Fleury-Feith; E Escudier; J Tran Van Nhieu; J F Bernaudin; C Cordonnier
Journal:  Support Care Cancer       Date:  1996-11       Impact factor: 3.603

5.  Pulmonary alveolar proteinosis: prospective clinical experience in 23 patients for 15 years.

Authors:  K Kariman; J A Kylstra; A Spock
Journal:  Lung       Date:  1984       Impact factor: 2.584

6.  Localized pulmonary alveolar proteinosis: two case reports.

Authors:  Seon Jeong Oh; Ji Yung Choo; Ki Yeol Lee; Je-Hyeong Kim; Suk Keu Yeom
Journal:  Balkan Med J       Date:  2014-09-01       Impact factor: 2.021

7.  Viral pneumonia and pulmonary alveolar proteinosis: the cause and the effect, case report.

Authors:  Saeed Mishal Albogami; Abdelfattah A Touman
Journal:  AME Case Rep       Date:  2019-10-16

8.  Classification and morphometric quantitation of insoluble materials from the lungs of patients with alveolar proteinosis.

Authors:  L B Gilmore; F A Talley; G E Hook
Journal:  Am J Pathol       Date:  1988-11       Impact factor: 4.307

9.  Pulmonary alveolar proteinosis. A spontaneous and inducible disease in immunodeficient germ-free mice.

Authors:  T Warner; E Balish
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

10.  Surfactant protein D. Increased accumulation in silica-induced pulmonary lipoproteinosis.

Authors:  E Crouch; A Persson; D Chang; D Parghi
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.